PowerShares Dynamic Biotech & Genome Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (24)

Latest Posts

About This Stock More About This Stock
The Landscape Of Biotech ETFs
Article By: Nancy Zhang
Tuesday, January 8, 2019 2:17 AM EST
The challenge is to create a quality biotech index with a rule-based system, so the picking and re-balancing are handy and quick.
In this article: IBB, PBE, BBC, CNCR
Should You Invest In The Invesco Dynamic Biotechnology & Genome ETF (PBE)?
Article By: Sweta Killa
Thursday, November 22, 2018 1:05 PM EST
Investor-friendly, sector ETFs provide many options to gain low risk and diversified exposure to a broad group of companies in particular sectors.
In this article: PBE Also: IBB, AMGN, BIIB, VRTX, XBI
M&A Waves Pushing Biotech ETFs Higher
Article By: Sweta Killa
Thursday, January 18, 2018 2:16 PM EST
The biotech corner of the broad healthcare sector is in the spotlight to start the New Year, as the new tax legislation has enticed U.S. companies to bring offshore cash back home, sparking waves of mergers and acquisitions.
In this article: FBT, PBE, BBC, CNCR Also: CELG, JUNO
4 Frightful ETFs Of This Year
Article By: Zacks Investment Research
Thursday, October 27, 2016 3:38 PM EST
Solar stocks are victims of the general misconception that oil price and solar market fundamentals are directly related to each other. Further, weak earnings from a few industry bellwethers weighed on solar ETFs.
In this article: KWT, BBC, SBIO, PBE Also: VXX, VIXY, VIIX, TAPR, TAN
Biotech ETF Industry Outlook
Article By: Zacks Investment Research
Sunday, September 4, 2016 7:29 PM EST
Sector-specific issues like increasing political and media focus on high price tags for new drugs and the changing competitive scenario have been weighing on biotech stocks over the last few quarters but the sector’s fundamentals remain strong.
In this article: IBB, BBH, FBT, PBE, XBI


Latest Tweets for $PBE

No tweets yet!